This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Reagan Udall Foundation hosted a meeting on PTSD treatment needs, with experts and stakeholders highlighting gaps and potential therapies, including MDMA-assisted therapy.
Greetings! Welcome to the Physiology Friday newsletter. Thanks to the premium sponsor of this newsletter: FSTFUEL electrolyte supplement. FSTFUEL combines electrolytes with amino acids to help your body maintain hydration and optimal functioning during exercise or intermittent fasting, so you don't have to choose between fasting and fitness. It’s a zero-sugar electrolyte drink that tastes awesome.
You are shown the ECG in Figure-1 — told only that the patient had a “continuous" tachycardia. QUESTIONS: How would YOU interpret the ECG in Figure-1 ? What is the differential diagnosis? — Treatment? Figure-1: The initial ECG in today's case. ( To improve visualization — I've digitized the original ECG using PMcardio ). MY Thoughts on the ECG in Figure-1: The rhythm in Figure-1 — is a regular SVT ( S upra V entricular T achycardia ) at a rate just under 150/minute , without clear sign of sinus
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
If you spend long enough thinking about health, you will come to a singular realisation: Regardless of how long you live or how good your physical or cognitive capabilities are, how you spend your time will have the biggest impact on the quality of your life. This is the domain of soul span. Soul span is about how you optimise for meaning and purpose in your life.
Heart failure (HF) is a prevalent and complex condition that demands precise and efficient management. This paper delves into a critical, yet often under-recognised, challenge in HF care – the accurate coding of patients on HF registers. We explore how discrepancies in coding, including missing patients and incorrect HF type classifications, can significantly impact patient management.
Publication date: Available online 5 September 2024 Source: The American Journal of Cardiology Author(s): Vincent Chen, Barry R. Davis, Samir R. Kapadia, Michael W. Kattan, Larisa G.
Stroke: Vascular and Interventional Neurology, Volume 4, Issue 6 , November 1, 2024. BackgroundFlow diversion has emerged as a promising treatment strategy for intracranial aneurysms, yet the influence of antiplatelet therapy on treatment outcomes remains uncertain. Regional and institutional variability in antiplatelet regimens further complicates treatment standardization.
Barratt reflects on recent therapeutic developments in IgAN, the most recent being the full FDA approval of sparsentan (Filspari), and the importance of preventing kidney failure.
Dear Sirs, In the recent article ‘Drug therapies for stroke prevention’, under the heading entitled ‘Control of blood pressure’, the authors specified that “A systolic blood pressure (SBP) target of 120–129 mmHg should be routinely aimed for in those <65 years old….”. 1 This ‘goal’ SBP does not take recognition of the fact that the goal SBP that optimally mitigates the risk of incident atrial fibrillation (AF) and, hence, cardioembolic stroke, is a SBP <120 mmHg.
The August 2024 cardiology month in review highlights critical data from the European Society of Cardiology Congress 24 and the latest updates on finerenone.
The British Cardiovascular Society (BCS) annual conference returned to the Manchester Central Convention Complex on the 3–5 June 2024. This year’s focus was our most important stakeholder, the patient – highlighting how research, pharmaceutical and technological advancements are improving patient outcomes, and the importance of value-based care.
Findings support the use of FIB-4’s low cut-off for ruling out severe fibrosis and cirrhosis as well as the use of Forns index’s high cut-off for significant fibrosis in chronic HCV.
There is little doubt that demand on the National Health Service (NHS) has exceeded supply. Given the rhetoric of no more money, no new workforce, and no new estates, it is incumbent on us all to make better and more efficient use of the limited resource we do have, improve how we work together as one integrated health, community and social care ecosystem, and increase the value of every action we take.
Publication date: Available online 5 September 2024 Source: The American Journal of Cardiology Author(s): Muhammad Shahzeb Khan, Rohan Kumar Ochani, Javed Butler
In this four-part editorial series, we have looked at the significance of research within cardiology training in the UK. The first three instalments explored the impact of research on a career in cardiology, identified the diverse research avenues, and provided guidance on navigating the application process. In the final part of this series, our focus shifts to post-higher degree opportunities within the field, and discuss the skills developed in research that can be applied to clinical practice
Publication date: Available online 5 September 2024 Source: The American Journal of Cardiology Author(s): Hristo Kirov, Tulio Caldonazo, Angelique Runkel, Darko Medin, Johannes Fischer, Luis Roberto Dallan, Murat Mukharyamov, Omar A. Mejia, Fabio B.
Publication date: Available online 6 September 2024 Source: The American Journal of Cardiology Author(s): Thomas O'Toole, Nishant P. Shah, Stephanie Nicole Giamberardino, Lydia Coulter Kwee, Deepak Voora, Robert W. McGarrah, Maros Ferencik, Michael T. Lu, William E. Kraus, Borek Foldyna, Pamela S. Douglas, Svati H. Shah, Neha J.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content